MAPK7 and prostate carcinoma: Given the fact that nuclear ERK5 is associated with proliferation, invasion and bad prognosis in prostate cancer [21,25], it is likely that this scenario of enhanced SUMOylation dynamics could result in favoring ERK5 SUMOylation and, therefore, ERK5 nuclear localization.